Cite
HARVARD Citation
Rouyer, M. et al. (2021). Effectiveness of first‐line cetuximab in wild‐type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort. British journal of clinical pharmacology. 87 (3), pp. 1120-1128. [Online].